ATI RN
ATI Pharmacology Questions
Question 1 of 5
While caring for a client receiving epoetin alfa to treat anemia, which finding should the nurse monitor for?
Correct Answer: B
Rationale: In caring for a client receiving epoetin alfa to treat anemia, the nurse should monitor for hypertension. Epoetin alfa is a medication that stimulates red blood cell production, which can lead to an increase in blood pressure. Monitoring for hypertension is crucial to prevent complications such as stroke or heart failure. Leukocytosis (option A) is an increase in white blood cells, which is not typically associated with epoetin alfa administration. Hyperkalemia (option C) is high levels of potassium in the blood, which is not a common side effect of epoetin alfa. Fever (option D) is also not a direct effect of epoetin alfa but could be a sign of infection, which should be monitored but is not the primary concern with this medication. Educationally, understanding the side effects and monitoring parameters for medications like epoetin alfa is crucial for safe and effective patient care. Nurses need to be able to recognize and respond to potential complications promptly to ensure positive patient outcomes.
Question 2 of 5
When starting therapy with bicalutamide, a client should be instructed to monitor for which of the following adverse effects?
Correct Answer: C
Rationale: In starting therapy with bicalutamide, it is crucial for the client to monitor for gynecomastia as the correct answer (Option C). Bicalutamide is an androgen receptor antagonist commonly used in the treatment of prostate cancer. Gynecomastia, the development of breast tissue in males, is a known side effect of bicalutamide due to its anti-androgenic properties. Educating the client about this potential adverse effect is important for early detection and management. Muscle pain (Option A) is not a commonly associated adverse effect of bicalutamide. Flushing (Option B) is also not a typical side effect of this medication. Hyperglycemia (Option D) is more commonly associated with other classes of medications like corticosteroids or certain antipsychotics, rather than bicalutamide. In an educational context, understanding the potential adverse effects of medications is crucial for safe and effective patient care. Teaching clients about expected side effects empowers them to monitor their own health and report any concerning symptoms promptly. This knowledge also helps healthcare providers to tailor monitoring plans and interventions to ensure the best outcomes for their patients.
Question 3 of 5
When providing teaching to a client starting therapy with trastuzumab, which finding should the nurse instruct the client to report?
Correct Answer: A
Rationale: In this scenario, the correct answer is A) Dyspnea. Trastuzumab is a monoclonal antibody used in the treatment of breast cancer. Dyspnea can be a sign of a serious side effect called pulmonary toxicity, which is a rare but potentially life-threatening complication of trastuzumab therapy. Therefore, it is crucial for the client to report any new or worsening respiratory symptoms promptly to their healthcare provider. Option B) Constipation is incorrect because it is not typically associated with trastuzumab therapy. Option C) Tinnitus is also incorrect as it is not a common side effect of this medication. Option D) Dry mouth is not a priority finding to report when starting trastuzumab therapy. From an educational perspective, it is essential for nurses to understand the common side effects and potential serious adverse reactions associated with specific medications to provide safe and effective patient care. Teaching clients to recognize and report concerning symptoms promptly can help prevent complications and improve treatment outcomes.
Question 4 of 5
When caring for a client receiving treatment with irinotecan, which of the following findings should the nurse monitor?
Correct Answer: A
Rationale: In caring for a client receiving irinotecan, monitoring for diarrhea is crucial due to its association with this medication. Irinotecan is known to cause severe diarrhea, which can lead to dehydration, electrolyte imbalances, and potentially life-threatening complications like sepsis. By closely monitoring for diarrhea, the nurse can intervene promptly to manage symptoms and prevent complications. Hypertension is not typically associated with irinotecan, making option B incorrect. Ototoxicity is a side effect more commonly seen with certain antibiotics and chemotherapeutic agents like cisplatin, not irinotecan, rendering option C incorrect. Neutropenia is a common adverse effect of many chemotherapy drugs, but it is not a primary concern with irinotecan, making option D incorrect in this context. Educationally, understanding the side effect profile of specific medications is essential for nurses to provide safe and effective care to patients. By knowing the expected side effects of irinotecan, nurses can anticipate, monitor, and manage these effects, improving patient outcomes and quality of care.
Question 5 of 5
A client is starting therapy with cisplatin. Which of the following findings should the nurse instruct the client to report?
Correct Answer: A
Rationale: Tinnitus should be reported by the client as it can be indicative of ototoxicity, an adverse effect associated with cisplatin therapy. Ototoxicity can result in damage to the inner ear structures, leading to hearing problems. Therefore, prompt reporting of tinnitus is essential for early intervention and prevention of potential complications.